Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-616-2 | CAS number: 123-30-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Exposure related observations in humans: other data
Administrative data
- Endpoint:
- exposure-related observations in humans: other data
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Clinical evaluation of pharmacokinetic absorption using human subjects
Data source
Referenceopen allclose all
- Reference Type:
- publication
- Title:
- Percutaneous absorption (PA) of phenols in vivo
- Author:
- Bucks, D.A.W. et al
- Year:
- 1 987
- Bibliographic source:
- Clin. Res., 35 (3) 672 A (1987)
- Reference Type:
- publication
- Title:
- Percutaneous penetration and mass balance accountability: technique and implications for dermatology
- Author:
- Bucks, D.A.W., et al.
- Year:
- 1 989
- Bibliographic source:
- J Toxicol - Cut & Ocular Toxicol 9 (2) 439-451 (1989/1990)
Materials and methods
- Type of study / information:
- Dermal absorption of 4-aminophenol in human volunteers
- Endpoint addressed:
- dermal absorption
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Application of known quantity of radioactively labelled compound under controlled conditions and collection of urine for quantification
- GLP compliance:
- no
Test material
- Reference substance name:
- 4-aminophenol
- EC Number:
- 204-616-2
- EC Name:
- 4-aminophenol
- Cas Number:
- 123-30-8
- Molecular formula:
- C6H7NO
- IUPAC Name:
- 4-aminophenol
Constituent 1
Method
- Ethical approval:
- confirmed, but no further information available
- Details on study design:
- The percutaneous absorption of PAP was evaluated in a study using 5 human volunteers.
2 μg/cm² of 14C-labelled PAP in 95% ethanol was applied to the bend of the forearm over a total
surface area of 2.5 cm². The application time was not specified. Urine from each subject was
collected over a seven day period and the radioactivity recovered was quantified. - Exposure assessment:
- measured
- Details on exposure:
- The 14C -labeled 4-aminophenol (Miravek Biochemicals, Inc., Brea, CA) was applied in 95% ethanol solution to the ventral forearm of healthy male volunteers (n≥5).
Chemical and radioactive dosages were 2-4 μg/cm² and 1 μgCi cm², respectively.
The area of application was 2.5 cm² and the dose was administered in 20 μL of volatile solvent.
In site-covered studies after evaporation of the vehicle (0.5 min.), the application site was either covered with an occlusive, semirigid, polyethylene-vinyl acetate copolymer, chamber or a nonocclusive, “ventilated,” modified chamber. In both cases, the chambers were affixed to the skin with hypoallergenic adhesive tape. The nonwoven, absorbent cotton pads with which the chambers are supplied were removed prior to use.
The subjects collected their urine for 7 days after application of 14C-labelled 4-aminophenol. Urine volumes were determined gravimetrically for each time period, and duplicate 3-5 mL aliquots were analyzed for radioactivity. The percentage of “dose” ( as total radioactivity) excreted was determined for each time interval. At 24 hr after dosing, the chamber was removed, placed in scintillation fluid, and the sequestered 14C quantified (since the chamber is in direct contact with skin). The application site was washed using a standardized procedure with five cotton balls consecutively soaked in soap solution (Ivory Liquid Soap, Procter and Gamble Co., Cincinnati, OH, diluted 1:1 with water), water, soap solution, water, and water. All washes were collected and processed for liquid scintillation counting to assay for residual surface 14C-labelled 4-aminophenol. For the remaining 6 days of the urine collection period, the administration site was again covered with a new chamber. Finally, this chamber was also assayed for 14C-labelled chemical by liquid scintillation counting. The application site was also washed as described above. In the latter studies, after being washed, the stratum corneum at the site of application was striped 10 tomes with adhesive tape and the skin tape strips analyzed for residual radioactivity by liquid scintillation counting.
Results and discussion
- Results:
- The dermal absorption of PAP was determined to be 13% (study published in 1987) of the applied dose. In a subsequent study
performed by the same investigators using similar dosing and urine collection regimens,
penetration was determined to be 6-8% (study published in 1989).
Any other information on results incl. tables
Table 1. Accountability of applied 14C in percentage of dose (1989/1990 publication)
Percutaneous Absorption | 1st Chamber |
1st Wash |
2nd Chamber |
2nd Wash |
Tape Strips |
Total | |
Occluded study | 8.1 | 15 | 36 | 1.8 | 2.4 | 63 | |
Protected study | 6 | 30 | 48 | 2.6 | 3 | 1.6 | 91 |
Applicant's summary and conclusion
- Conclusions:
- Two studies in humans evaluating absorption of 4-aminophenol were conducted and it was determined that absorption under occluded conditions when ethanol was used as a solvent was between 6 and 13%. For the purposes of risk assessment, it can be assumed that about 10% absorption of a potential dermal exposure may be absorbed based on the available data and therefore a factor of 10 may be used as the difference between oral and dermal absorption.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
